The results of a randomized controlled trial performed in Spain suggest that cognitive behavior therapy (group sessions comprising cognitive restructuring and coping strategies) is more effective than recommended pharmacologic therapy (pregabalin and duloxetine) in terms of key fibromyalgia outcomes, such as function and quality of life, and also mediators of treatment effects, such as pain catastrophizing and acceptance.